Haematology

Doç. Dr. Merve Pamukçuoğlu

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
Multiple Myeloma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workMultiple MyelomaExtracted from 3 publications · Model version —From source
  • Publications42 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-4591-2025ORCIDFrom source
  • Last synchronised5 November 2026 07:22https://ankarasehir.saglik.gov.tr/TR-331019/hematoloji-klinigi-doktorlarimiz.html#merve-pamukcuoglusaglik.gov.tr

Scientific work

Publications on Multiple Myeloma

42 publications

  1. Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

    Mediterranean Journal of Hematology and Infectious Diseases, 2026

    DOI 10.4084/mjhid.2026.044 PMID 42136896 Open-access full textSource: ORCID

  2. Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms

    International Journal of Endocrinology, 2026

    DOI 10.1155/ije/6041016 PMID 42147090 1 citation (Europe PMC) Open-access full textSource: ORCID

  3. Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors

    Journal of Clinical Apheresis, 2026

    DOI 10.1002/jca.70089 PMID 41500932 Open-access full textSource: ORCID

  4. Endocrine Complications in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: Prevalence and Risk Factors

    Selcuk Medical Journal, 2026

    DOI 10.30733/std.2026.01940 Open-access full textSource: ORCID

  5. Akut Miyeloid Lösemi Hastalarında Kemik İliği Fibrozisinin Sağkalım Üzerine Olan Etkisi

    LLM Dergi, 2025

    DOI 10.5578/llm.202503193 Open-access full textSource: ORCID

  6. Turkish Society for Rheumatology guideline for the management of ANCA-associated vasculitides

    Ulusal Romatoloji Dergisi, 2025

    DOI 10.4274/raed.galenos.2025.26349 Open-access full textSource: OpenAlex

  7. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia

    Clinical Lymphoma Myeloma and Leukemia, 2024

    DOI 10.1016/j.clml.2023.12.015 PMID 38342726 7 citations (Europe PMC) Source: ORCID

  8. Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma

    Nigerian Journal of Clinical Practice, 2024

    DOI 10.4103/njcp.njcp_726_23 PMID 39212439 Open-access full textSource: ORCID

  9. MANTLE CELL LYMPHOMA PATIENT WITH SKIN GVHD AFTER AUOTOLOGOUS STEM CELL TRANSPLANT

    Hematology Transfusion and Cell Therapy, 2024

    DOI 10.1016/j.htct.2024.11.014 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. Effect of Mobilization Methods on CD34+ and Total Nucleated Cell Count and Their Relation with Engraftment in Autologous Hematopoietic Stem Cell Transplantation

    Eastern Journal Of Medicine, 2024

    DOI 10.5505/ejm.2024.08624 Open-access full textSource: OpenAlex

View all 42 publications